Please login to the form below

Not currently logged in
Email:
Password:

Teva’s chair Philip Frost to step down

He will leave the Israeli pharma company by the end of the year

teva phillip frost Teva's chairman Phillip Frost will resign his position by the end of 2014.

According to Reuters Frost (pictured right) wrote to shareholders in a letter: "With the progress we have made, and continue to make, at Teva, I have advised the board that I believe it will be appropriate for me to step down as chairman approximately by the end of this year.”

The announcement comes just three weeks after Israel-based Teva announced a restructure of its business to give stronger identify to its branded and generics divisions, including several new senior appointments.

The past few months has been a time of transition for Teva; the company also saw a change in CEO with the appointment of Erez Vigodman to replace Jeremy Levin, who, according to local news reports, had a strained relationship with Frost.

And at the beginning of 2014, the company announced that board director Amir Elstein to replace Prof Moshe Many as vice chairman.

20th June 2014

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Oxford University Press

Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...

Latest intelligence

Sustainability
Environment: where does the pharmaceutical industry stand?
...
The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...